Respiratory Infections News

Neurological symptoms were among the most common clinical manifestations of COVID-19, with anosmia, myalgia and headache being the most frequently reported, data show.

A final analysis showed that Novavax’s COVID-19 vaccine was 96.4% efficacious against mild, moderate or severe disease caused by wild SARS-CoV-2 in a phase 3 trial in the United Kingdom, the company said.

Many nurses in the United States continue to face significant risks amid the COVID-19 pandemic because they lack support from their employers, according to a recent survey.

Ten percent of employees at two hospitals in Philadelphia said they did not intend to receive the COVID-19 vaccine, survey data published in Vaccine showed.

On the 1-year anniversary of WHO declaring a pandemic over COVID-19, the Infectious Diseases Society of America convened a press briefing to discuss reopening schools.

Several European countries, including Denmark and Norway, halted vaccinations with AstraZeneca’s COVID-19 vaccine over reports of blood clots in vaccinees.

The impact of COVID-19 in pregnancy was “severe” among a cohort of HIV-positive women in South Africa, researchers reported at the Conference on Retroviruses and Opportunistic Infections.

Results from multiple studies suggest that halving the two-dose series of COVID-19 messenger RNA vaccines may be sufficient to protect people who have recovered from COVID-19.

A 4-month daily regimen of rifapentine and moxifloxacin was noninferior to the standard 6-month regimen for tuberculosis treatment among people with HIV enrolled in a phase 3 clinical trial, researchers reported at CROI.

A 5-day course of antibiotics was just as effective as the standard 10-day course in treating community-associated pneumonia in nonhospitalized children, according to a study published in JAMA Pediatrics.